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osting by EAbstract Introduction: Sudden cardiac death among professional young athletes has become a
signiﬁcant concern mainly attributed to structural heart changes and ECG abnormalities.
Objectives: We aimed primarily to compare echocardiographic and electrocardiographic changes
in young professional athletes versus a control group of sedentary lifestyled nonathletic individuals
of the same age group. Secondly, we aimed to follow up echocardiographic and electrocardio-
graphic changes in young professional athletes after one year.
Methods: We conducted the study from May 2008 to May 2009 by clinical examination, transthor-
axic echocardiography and 12 lead ECG. Our study group was the national football team candi-
dates for the youth world cup occurring in Cairo 2009. This study group was compared to a
control group of randomly picked nonathletic third year medical students after exclusion of anyone
with a known medical illness. The study group was classiﬁed into Athletes I representing athletes at
the beginning of the study and Athletes II representing athletes after one year follow up.
Results: The Study group comprised 34 males, mean age 18.82 ± 1.56 years while the Control
group comprised 28 males, age mean 19.64 ± 2.31 years. There was not a signiﬁcant difference
between the two groups regarding number, age, height or weight (P> 0.05).
Athletes I vs control: Clinical parameters showed signiﬁcantly lower Systolic Blood Pressure SBP
(athletes 117.79 ± 6.536, control 126.43 ± 17.043, P= 0.008) and Heart Rate HR (athletes
68.88 ± 5.044, control 77.43 ± 6.033, P= 0.001). ECG parameters showed a signiﬁcantly longer
RR interval (athletes 0.88 ± 0.065, control 0.76 ± 0.078, P= 0.001), while Corrected QTc interval
was not signiﬁcantly different (athletes 0.41 ± 0.029, control 0.42 ± 0.022, P> 0.05). Echo param-
eters showed a signiﬁcant increase in Ejection fraction EF (athletes 60.94 ± 3.084 vs control(Y.S. Nassar).
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14 Y.S. Nassar et al.54.14 ± 13.063, P= 0.005) and Left atrial dimension LA (athletes 3.28 ± 0.392 vs control
2.58 ± 1.321, P= 0.005). On the other hand Septal wall in diastole SWD, Right ventricle dimen-
sion RV, Left ventricular end systolic dimension LVESD, Left Ventricular End Diastolic Dimen-
sion LVEDD, Aortic Root AO, and Posterior wall in diastole PWD were not signiﬁcantly
different (P> 0.05).
Athletes II vs control: QTc became signiﬁcantly longer (athletes 0.43 ± 0.028 vs control
0.42 ± 0.022, P= 0.05). SWD was signiﬁcantly thicker (athletes 1.21 ± 0.23 vs control
1.07 ± 0.17, P= 0.04). SBP, HR remained signiﬁcantly lower and RR, EF, LA remained signiﬁ-
cantly greater (P< 0.05), while RV, LVESD, LVEDD, AO, PWD remained not signiﬁcantly dif-
ferent both at the beginning and also after 1 year (P> 0.05).
Athletes I vs athletes II: ECG parameters showed a signiﬁcant increase in QTc (0.41 ± 0.029 vs
0.43 ± 0.028, P= 0.005) and RR interval (0.81 ± 0.167 vs 0.88 ± 0.065, P= 0.046). Echo param-
eters showed a signiﬁcant increase in SWD (1.21 ± 0.232 vs 0.93 ± 0.124, P< 0.001), LA
(3.62 ± 0.423 vs 3.28 ± 0.392, P= 0.001), RV (2.37 ± 0.565 vs 2.09 ± 0.234, P= 0.011), PWD
(1.00 ± 0.200 vs 0.90 ± 0.200, P= 0.008), and a signiﬁcant decrease in LVESD (3.19 ± 0.679
vs 3.48 ± 0.190, P= 0.016). Other parameters were not statistically signiﬁcant (P> 0.05).
Conclusions: Professional football playing in young males results in signiﬁcant changes compared
to their control of sedentary nonathletic medical students of similar age. Clinical parameters
showed a signiﬁcant decrease in systolic blood pressure SBP and heart rate HR, ECG parameters
showed signiﬁcant increase in RR interval and QTc interval, and Echocardiographic parameters
showed a signiﬁcant increase in Left atrium diameter LA, Septal wall in diastole SWD, and ejection
fraction EF. One year of professional football playing in young males causes a continuing signiﬁ-
cant increase in ECG parameters QTc, RR interval, and echocardiographic parameters SWD, LA,
Right ventricle dimension RV, Posterior wall in diastole PWD and decrease in Left ventricular end
systolic diameter LVESD compared to themselves one year earlier. The international concern of
Sudden cardiac death among professional young athletes may be attributed to Structural heart
changes and ECG abnormalities acquired with professional training.
ª 2011 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Regular physical activity has several beneﬁcial effects on
health and is linked with reduced cardiovascular and all-cause
mortality. However, in certain circumstances, an acute bout of
exertion may cause dangerous health effects and, in extreme
cases, sudden death (the so called ‘‘paradox of exercise’’).
Competitive athletics has been deﬁned as ‘‘participation in
an organized team or individual sport that requires regular
competition against others as a central component, that places
a high premium on excellence and achievement and requires
some form of systematic training’’.1
Although rare, the sudden death of a young athlete is a dra-
matic event with a devastating impact on his family, sports
community, and medical staff. It was the case of professional
soccer player Marc-Vivien Foe from Cameroon (28 years
old), who died suddenly while playing in the Confederations
Cup, due to a hypertrophic cardiomyopathy, or, more re-
cently, of the Spanish soccer player Antonio Puerta (22 years
old) who had a syncope on the ﬁeld, with spontaneous recov-
ery and a new collapse in the locker room due to a fatal cardiac
arrest.2
Dealing with exercise-related sudden death (ESD), we usu-
ally refer to an unexpected and witnessed sudden cardiac arrest
occurring within 1 hour from an exercise bout in an apparently
healthy person.
Following this deﬁnition, ESD is rare, with an incidence of
1/100000 to 1/300000 per year in males. This explains why,still today, experts discuss on the usefulness of a routine med-
ical pre-participation screening in preventing ESD.3
It is largely demonstrated that cardiovascular diseases play
the dominant role in ESD, accounting for 80–85% of cases.
Usually, the fatal cardiac arrest occurs either during or imme-
diately after strenuous exercise, suggesting that autonomic ner-
vous system changes related to effort may trigger malignant
arrhythmias in subjects with cardiac disease. This aspect is
indirectly conﬁrmed by the fact that ESD is more frequent dur-
ing ofﬁcial events in respect to training sessions, probably be-
cause of the greater psychological involvement.Aim of the
work:
1. Compare echocardiographic and electrocardiographic
changes in young professional athletes versus a control
group of sedentary life styled nonathletic individuals of
the same age group.
2. Follow up echocardiographic and electrocardiographic
changes in those young professional athletes group after
one year.
3. Providing limitation criteria for eligibility of competition
and suitable sports for athletes at risk for SCD.
2. Patients and methods
This study was conducted in Critical Care Medicine Depart-
ment Cairo University in the period from May 2008 to May
One year cardiac follow up of young world cup football team compared to nonathletes 152009.Our study group was picked up from the national foot-
ball team candidates for the youth world cup occurring in
Cairo 2009. This study group was compared to a control group
of randomly picked nonathletic third year medical students
after exclusion of anyone with a known medical illness.
The study group was classiﬁed into:
[I] Athletes I representing athletes at the beginning of the
study and
[I] Athletes II representing athletes after one year follow
up.
2.1. Patients
2.1.1. Inclusion Criteria
1. Study group:
Athletes, males, age between 17 and 22 years.
Practicing football in a professional manner.
The study group was examined in the beginning of the
study (athletes I) and one year later (athletes II).
2. Control group:
Nonathletic, males, age between 17 and 22 years.
The study group was compared to a control group of ran-
domly picked nonathletic third year medical students.
2.1.2. Exclusion Criteria
Known congenital heart disease.
Implantable cardioverter deﬁbrilator or pacemaker implan-
tation.
Hypertension.
Any chronic disease as liver, kidney, autoimmune, . . . , etc.2.2. Methods
2.2.1. All individuals in both groups were subjected to
Thorough history taking: Chest pain, syncopal attacks, palpi-
tation, high blood pressure and family history of sudden car-
diac death.
(1) General and clinical examination:
1. Weight: using a standard weight calculating machine to
all subjects.
2. Height: Was measured by a standard against the wall
measure.
3. Arm span to height ratio and other examinations to
exclude Marfan syndrome (ratio more than 1.05 is sig-
niﬁcant) criteria.
General Clinical Examination including:
1. Blood pressure SPB and DBP
2. Cardiac Auscultation
3. Abdominal examination
(2) Electrocardiogram ECG:12-lead ECG was done to all subjects to evaluate the car-
diovascular condition.
Variables of comparison were:
RR interval: from the R to the next R.
PR interval: from the beginning of the P to the beginning of
the QRS.
QT interval: from the beginning of the QRS to the end of T
wave.
Corrected QTðQTcÞ ¼ QT interval in secondﬃﬃﬃﬃ
R
p Rinterval in second :
(3) Echocardiography:
Transthoracic echocardiography was done to every candi-
date in both groups at the beginning and to the study group
after one year follow up.
The following variables were measured:
Left ventricular end diastole (LVEDD 3.5–5.6 cm)
Left ventricular end systole (LVESD)
Left atrial dimensions (LA 2.5–4 cm).
Ejection fraction (EF more than 50%).
Interventricular septum (IVS 0.6–1.1 cm) in diastole.
Posterior wall thickness (PWd 0.6–1.1 cm) in diastole.
Right ventricle dimention (RV 0.7–2.5 cm).
Aortic root (AO 2.5–4 cm).2.3. Statistical methods
Data were coded and entered using the statistical package
SPSS (Self-Propelled Semi-Submersible) version 15.
Data were summarized using mean and standard deviation
for quantitative variables & percent for quantitative vari-
ables, compare between groups was done using chi-square
for qualitative variables and independent samples T-test
for normal distributed quantitative variables while quanti-
tative variables not normally distributed were compared
using non-parametrical Mann-Whitney test and Wilcoxon
signed rank test.
P-value < 0.05 was considered statistically signiﬁcant.3. Results
We conducted the study from May 2008 to May 2009 in the
critical care medicine department, Cairo University.
The athletes study group comprised 34 males picked from
members of the football youth teams at Al Ahly football club.
This study group was classiﬁed into:
1. Athletes I: represented the athletes at the beginning of
the study.
2. Athletes II: represented the athletes one year later in
follow up.
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Figure 1 Mean heart rate in study versus control groups.
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nonathletic third year medical students after exclusion of any-
one with a known medical illness.
Our results will be discussed under the following items:
(A) Baseline and clinical parameters
(B) Electrocardiographic parameters.
(C) Echocardiographic parameters.
(A) Baseline and clinical data:
1. The mean age for athletes was 18.82 ± 1.566 years
while it was 19.64 ± 2.313 years in the control group.
There was no signiﬁcant statistical difference between
the two groups regarding the age (P> 0.05).
2. The mean height Ht in athletes was 176.15 ± 5.533 cm
while it was 177.04 ± 6.472 cm in the control group
without signiﬁcant statistical difference between the
two groups (P> 0.05).
3. The mean weight Wt of athletes was 72.29 ± 5.579 kg
while in the control group it was 74.82 ± 13.944 kg
with no signiﬁcant statistical difference between the
two groups regarding the weight (P> 0.05).
4. Body Surface Area BSA in athletes was 1.87 ± 0.1
while it was 1.91 ± 0.180 in control group without sig-
niﬁcant statistical difference between the two groups
(P> 0.05).
5. Systolic blood pressure SBP was signiﬁcantly lower in
athletes compared to control (117.79 ± 6.536 mmHg
vs 126.43 ± 17.043 mmHg, P= 0.008), respectively.
6. Diastolic blood pressure DBP showed no signiﬁcant sta-
tistical difference between the two groups (74.41 vs
76.79, P= 0.32).
7. The mean Heart Rate HR in (athletes I) (68.88 ±
5.044) was signiﬁcantly lower than control (77.43 ±
6.033, P= 0.001) (Table 1).
While there was no such difference between athletes IITable
Age
Ht
Wt
BSA
SBP
DBP
HR
Figure 2 Mean RR interval in study versus control groups.
(72.97 ± 12.537) and control group (77.43 ± 6.033,
P= 0.09), as well as between (athletes I)
(68.88 ± 5.044) and athletes II (72.97 ± 12.537)
(P= 0.1) (Fig. 1).Table 2 The comparison between athletes I at the beginning
of study and athletes II after 1 year of professional sport
activity.
Athletes I (34 pts) Athletes II (34 pts) P-value
ECG parameters(B) Electrocardiographic data:
RR interval:
(1) Athletes I vs control: RR interval was signiﬁcantly
longer (0.88+0.065 vs 0.76+0.078, P 0.001)in athletes
I vs control, respectively (Table 3).1 Baseline and clinical data.
Athletes (34 pts) Control (28 pts) P-value
18.82 ± 1.566 19.64 ± 2.313 0.103
176.15 ± 5.533 177.04 ± 6.472 0.562
72.29 ± 5.579 74.82 ± 13.944 0.337
1.87 ± 0.101 1.91 ± 0.180 0.285
117.79 ± 6.536 126.43 ± 17.043 0.008
74.41 ± 5.609 76.79 ± 12.488 0.324
68.88 ± 5.044 77.43 ± 6.033 0.001(2) Athlete II vs control: RR interval was not signiﬁcantly
longer (0.81 ± 0.167 vs 0.76 ± 0.078, P: 0.153) in ath-
letes II vs control, respectively (Table 4).
(3) Athletes I vs athletes II: RR interval was signiﬁcantly
longer (0.88+0.065 vs 0.81+ 0.167, P 0.046) in athletes
I vs athletes II, respectively (Fig. 2, Table 2).
PR interval:
(1) Athletes I vs control: PR interval showed no signiﬁcant
statistical difference (149.03 ± 11.821 vs 139.57 ±
27.67) (P= 0.076) in athletes I vs control, respectively
(Table 3).
(2) Athlete II vs control: PR interval showed no signiﬁcant
statistical difference (143.59 ± 24.87 vs 139.57 ± 27.67HR 68.88 ± 5.044 72.97 ± 12.537 0.1
RR 0.88 ± 0.065 0.81 ± 0.167 0.046
PR 149.03 ± 11.821 143.59 ± 24.87 0.237
QRS 101.15 ± 3.66 102.74 ± 6.561 0.2771
QTc 0.41 ± 0.029 0.43 ± 0.028 0.005
Echo parameters
SWd 0.93 ± 0.124 1.21 ± 0.232 0.001
PWd 0.90 ± 0.106 1 ± 0.20 0.008
EF 60.94 ± 3.08 60.48 ± 10.53 0.85
LVEDd 4.79 ± 0.507 4.79 ± 1 0.987
LVESd 3.48 ± 0.19 3.19 ± 0.679 0.016
LA 3.28 ± 0.392 3.62 ± 0.423 0.001
AO 2.79 ± 0.329 2.7 ± 0.56 0.228
RV 2.09 ± 0.237 2.37 ± 0.565 0.01
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Figure 4 Mean QRS interval in study versus control groups.
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Figure 3 Mean PR interval in study versus control groups.
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4).
(3) Athletes I vs athletes II: PR interval showed no signiﬁ-
cant statistical difference (149.03 ± 11.821 vs
143.95 ± 24.844, P= 0.237) in Athletes I vs athletes
II, respectively (Fig. 3, Table 2).
The QRS:
(1) Athletes I vs control: The QRS showed no signiﬁcant
statistical difference (101.15 ± 3.661 vs 100.52 ± 5.867
P= 0.465) in athletes I vs control, respectively (Table
3).
(2) Athlete II vs control: The QRS showed no signiﬁcant
statistical difference (102.74 ± 6.561 vs 100.25 ±
5.867, P= 0.125) in athletes II vs control, respectively
(Table 4).
(3) Athletes I vs athletes II: The QRS showed no signiﬁcant
statistical difference (101.15 ± 3.66 vs 102.74 ± 6.561,
P= 0.2771) in athletes I vs athletes II, respectively
(Fig. 4, Table 2).Table 3 The comparison between athletes I and control.
Athletes I (34 pts) Control P-value
ECG parameters
HR 68.88 ± 5.044 77.43 ± 6.033 0.001
RR 0.88 ± 0.065 0.76 ± 0.078 0.001
PR 149.03 ± 11.821 139.57 ± 27.67 0.076
QRS 101.15 ± 3.66 100.25 ± 5.867 0.465
QTc 0.41 ± 0.029 0.42 ± 0.022 0.327
Echo parameters
SWd 0.93 ± 0.124 1.07 ± 0.179 0.001
PWd 0.90 ± 0.106 1.07 ± 0.225 0.0001
EF 60.94 ± 3.08 54.14 ± 13.06 0.005
LVEDd 4.79 ± 0.507 4.69 ± 0.635 0.461
LVESd 3.48 ± 0.19 3.48 ± 0.19 0.483
LA 3.28 ± 0.392 2.58 ± 1.321 0.005
AO 2.79 ± 0.329 2.63 ± 0.414 0.108
RV 2.09 ± 0.237 2.27 ± 0.492 0.073
Table 4 The comparison between athletes II after 1 year and
control.
Athletes II (34 pts) Control P-value
ECG parameters
HR 72.97 ± 12.537 77.43 ± 6.033 0.09
RR 0.81 ± 0.167 0.76 ± 0.078 0.153
PR 143.59 ± 24.87 139.57 ± 27.67 0.550
QRS 102.74 ± 6.561 100.25 ± 5.867 0.125
QTc 0.43 ± 0.028 0.42 ± 0.022 0.058
Echo parameters
SWd 1.21 ± 0.232 1.07 ± 0.179 0.012
PWd 1 ± 0.20 1.07 ± 0.225 0.202
EF 60.48 ± 10.53 54.14 ± 13.06 0.04
LVEDd 4.79 ± 1 4.69 ± 0.635 0.638
LVESd 3.19 ± 0.679 3.48 ± 0.19 0.142
LA 3.62 ± 0.423 2.58 ± 1.321 0.001
AO 2.7 ± 0.56 2.63 ± 0.414 0.61
RV 2.37 ± 0.565 2.27 ± 0.492 0.431QTc:
(1) Athletes I vs control: Corrected QTc interval was not
signiﬁcantly different (0.41 ± 0.029 vs 0.42 ± 0.022,
P> 0.05) in athletes I vs control, respectively (Table 3).
(2) Athletes II vs control: QTc became signiﬁcantly longer
(0.43 ± 0.028 vs 0.42 ± 0.022, P= 0.05) in athletes II
vs control, respectively (Table 4).
(3) Athletes I vs athletes II: Showed a signiﬁcant increase in
QTc (0.41 ± 0.029 vs 0.43 ± 0.028, P= 0.005) in ath-
letes I vs athletes II, respectively (Fig. 5, Table 2).
(C) Echocardiographic data:
The septal wall in diastole (SWd):
(1) Athletes I vs control: The septal wall in diastole (SWd)
was signiﬁcantly lower (0.93 ± 0.124 vs 1.07 ± 0.179
P= 0.001) in athletes I vs control, respectively (Table
3).
(2) Athletes II vs control: SWd was signiﬁcantly higher
(1.21 ± 0.232 vs 1.07 ± 0.179, P= 0.012) in athletes
II vs control, respectively.
(3) Athletes I vs athletes II: SWd showed a signiﬁcant
increase in (0.93 ± 0.124 vs 1.21 ± 0.232, P< 0.001)
in athletes I vs athletes II, respectively (Fig. 6).
The posterior wall in diastole (PWd):Control
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Figure 5 Mean QTc interval in study versus control groups.
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Figure 6 Mean SWd in study versus control groups.
18 Y.S. Nassar et al.(1) Athletes I vs control: The posterior wall in diastole
(PWd) was signiﬁcantly lower (0.90 ± 0.106 vs
1.07 ± 0.225, p= 0.001) in athletes I vs control,
respectively.
(2) Athletes II vs control: PWd showed no signiﬁcant statis-
tical difference (1 ± 0.20 vs 1.07 ± 0.225, P= 0.202) in
athletes II vs control, respectively.
(3) Athletes I vs athletes II: PWd showed a signiﬁcant
increase (0.90 ± 0.106 vs 1 ± 0.20, P: 0.008) in athletes
I vs athletes II, respectively (Fig. 7, Table 2).
Ejection Fraction:
(1) Athletes I vs control: Ejection fraction EF showed a sig-
niﬁcant increase (60.94 ± 3.084 vs 54.14 ± 13.063, P=
0.005) in athletes I vs control, respectively (Table 3).
(2) Athletes II vs control: EF remained signiﬁcantly greater
(60.48 ± 10.53 vs 54.14 ± 13.06, P= 0.04) in athletes
II vs control, respectively (Table 4).
(3) Athletes I vs athletes II: EF was not signiﬁcantly differ-
ent (60.94 ± 3.08 vs 60.48 ± 10.53, P= 0.85) in ath-
letes I vs athletes II, respectively (Fig. 8, Table 2).
The left ventricular end diastole (LVEDd):
(1) Athletes I vs control: LVEDd showed no signiﬁcant sta-
tistical difference (4.79 ± 0.507 vs 4.69+0.635, P=
0.461) in athletes I vs control, respectively (Table 3).control
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Figure 8 Mean ejection fraction in study versus control groups.
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Figure 7 Mean PWd in study versus control groups.(2) Athletes II vs control : LVEDd showed no signiﬁcant
statistical difference (4.79 ± 1 vs 4.69 ± 0.635, P:
0.638) in athletes II vs control, respectively (Table 4).
(3) Athletes I vs athletes II: LVEDd showed no signiﬁcant
statistical difference (4.79 ± 0.507 vs 4.79 ± 1, P:
0.987) in athletes I vs athletes II, respectively (Fig. 9,
Table 2).
The left ventricular end systole (LVESd):
(1) Athletes I vs control: The left ventricular end systole
LVESd showed no signiﬁcant statistical difference
(3.48 ± 0.19 vs 3.48 ± 0.19, P= 0.483) in athletes I
vs control, respectively (Table 3).
(2) Athletes II vs control: LVESd showed no signiﬁcant sta-
tistical difference (3.19 ± 0.679 vs 3.48 ± 0.19, P: 0.142)
in athletes II vs control, respectively (Table 4).
(3) Athletes I vs athletes II: LVESd show signiﬁcant
decrease (3.48 ± 0.19 vs 3.19 ± 0.679, P= 0.016) in
athletes I vs athletes II, respectively (Fig. 10, Table 2).
The left atrium LA:
(1) Athletes I vs control: LA show a signiﬁcant increase
(3.28 ± 0.392 vs 2.58 ± 1.321, P= 0.005) in athletes I
vs control, respectively (Table 3).
(2) Athletes II vs control: LA show a signiﬁcant increase
(3.62 ± 0.423 vs 2.58 ± 1.321, P= 0.001) in athletes
II vs control, respectively (Table 4).
(3) Athletes I vs athletes II: LA showed a signiﬁcant
increase (3.28 ± 0.392 vs, 3.62 ± 0.423 P: 0.001) in ath-
letes I vs athletes II, respectively (Fig. 11, Table 2).
The aortic root AO:
(1) Athletes I vs control: The aortic root AO showed no sig-
niﬁcant statistical difference (2.79 ± 0.329 vs
2.63 ± 0.414, P= 0.108) in athletes I vs control, respec-
tively (Table 3).control
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Figure 9 Mean LVEDd in study versus control groups.
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Figure 10 Mean LVESd in study versus control groups.
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Figure 11 Mean LA in study versus control groups.
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Figure 12 Mean AO in study versus control groups.
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cal difference (2.7 ± 0.56 vs 2.63 ± 0.414, P= 0.61) in
athletes II vs control, respectively (Table 4).
(3) Athletes I vs athletes II: AO showed no signiﬁcant statis-
tical difference (2.79 ± 0.329 vs 2.7 ± 0.56, P: 0.228) in
athletes I vs athletes II, respectively (Fig. 12, Table 2).
The right ventricle diameter RV:
(1) Athletes I vs control: The right ventricle RV showed no
signiﬁcant statistical difference (2.09 ± 0.237 vs 2.27 ±
0.492, P= 0.073) in athletes I vs control, respectively
(Table 3).
(2) Athletes II vs control: RV showed no signiﬁcant statisti-
cal difference (2.37 ± 0.565 vs 2.27 ± 0.492, P= 0.431)
in athletes II vs control, respectively (Table 4).
(3) Athletes I vs athletes II: RV was signiﬁcantly increased
(2.09 ± 0.237 vs 2.37 ± 0.565, P= 0.01) in athletes I
vs athletes II, respectively (Fig. 13, Table 2).
4. Discussion
Although regular physical activity has several beneﬁcial effects
on health and is linked with reduced cardiovascular and all-
cause mortality, in certain circumstances, an acute bout of2.09 2.37
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Figure 13 Shows mean RV inexertion may cause dangerous health effects and, in extreme
cases, sudden death.
We aimed primarily to compare echocardiographic and
electrocardiographic changes in young proffessional athletes
versus a control group of sedentary lifestyled nonathletic indi-
viduals of the same age group. Secondly, we aimed to follow
up echocardiographic and electrocardiographic changes in
young proffessional athletes after one year, and ﬁnally to rec-
ognize silent cardiovascular abnormalities to provide limita-
tion criteria for eligibility of competition for athletes at risk
of sudden cardiac death (SCD).
This study was conducted in Critical Care Medicine
Department Cairo University in the period from may 2008
to may 2009. Our study group was picked up from the national
football team candidates for the youth world cup occurring in
Cairo 2009.Our control group was randomly picked nonath-
letic third year medical students.
4.1. Regarding clinical parameters
In our athletes, systolic blood pressure (SBP) was 117.79 ±
6.536 mmHg while in control group, it was 126.43 ± 17.043
mmHg. SBP was signiﬁcantly lower in athletes I vs control
(P= 0.008).
While diastolic blood pressure (DBP) showed no signiﬁcant
statistical difference in athletes I vs control, respectively (74.41
vs 76.79, P> 0.05).
This comes in agreement with Eric Abergel et al.4 who
showed in a study done on 286 cyclists and 52 matched seden-
tary volunteers that Systolic blood pressure (120 ± 9 mm Hg
vs. 126 ± 13 mmHg, P< 0.05) and diastolic blood pressure
(68 ± 9 mmHg vs. 77 ± 10 mm Hg, P< 0.05) were lower in
athletes than in controls, as was heart rate.
In a study done by Hernelahti et al.5 on 264 male orienteer-
ing runners among men aged 35–59 years concluded that long-
term vigorous endurance training is associated with a low
prevalence of hypertension. Some of the effect can be ex-
plained by a lower body mass, but exercise seems to induce a
lower rate of hypertension by other mechanisms than by
decreasing body weight.
4.2. Regarding ECG parameters
Compared to controls, in our study the heart rate in athletes
was lower with RR interval longer signiﬁcantly than in control
(HR 68.88 ± 5.044 with RR 0.88 ± 0.065 vs HR 77.43 ±
6.033 with RR 0.76 ± 0.078, P 0.001) in athletes I vs control,
respectively. HR and RR interval was not signiﬁcantly chan-control
2.27
study versus control groups.
20 Y.S. Nassar et al.ged (HR 68.2 with RR 0.81 ± 0.167 vs HR 78.9 with RR
0.76 ± 0.078, P 0.153) in athletes II vs control, respectively.
Compared to themselves after one year of professional training,
HR was lower with RR longer signiﬁcantly (HR 68.2 with RR
0.88 ± 0.065 vs HR 74.1 with RR 0.81 ± 0.167, P= 0.046) in
athletes I vs athletes II, respectively.
This comes in agreement with Martinelli6 who found that
athletes at rest had lower heart rates in a study done on two
groups 10 cyclists and 11 sedentary group showed (HR
65.6 ± 10.49 with RR 0.91 vs HR 70.9 ± 10.75 with RR
0.85, P< 0.05) in athletes vs control, respectively. Similarly,
in a study done by Piraye Kervancioglu and Savas Hatipoglu7
on 40 male football players and 25 sedentary males showed
(HR 60.48 ± 6.71 with RR 1.00 vs HR 73.20 ± 3.44 with
RR0.82, P< 0.05) in athletes vs control, respectively. Simi-
larly, this comes in agreement with the study done by Lang-
deau et al.8 who made the study on 100 athletes and 50
control and found that athletes had signiﬁcantly longer RR
intervals (HR 54.5 with RR1.168.5 ± 21.6 vs HR 63.8 with
RR 0.943.6 ± 21.8, P< 0.05) in athletes vs control,
respectively.
The cause of bradycardia in athletic subjects is uncertain.
Most evidence suggests that the sinoatrial node and atrioven-
tricular nodes are suppressed by an increase in vagal tone,
which can be abolished by atropine or stopping training. In
athletes the resting bradycardia seems to be much more related
to changes in intrinsic mechanisms than to modiﬁcations in
autonomic control.9
Compared to controls, in our study QTc interval was not
signiﬁcantly different (0.41 ± 0.029 vs 0.42 ± 0.022, P>
0.05) in athletes I vs control, respectively. QTc became signif-
icantly longer (0.43 ± 0.028 vs 0.42 ± 0.022, P= 0.05) in ath-
letes II vs control, respectively. Compared to themselves after
one year of professional training, QTc showed a signiﬁcant in-
crease (0.41 ± 0.029 vs 0.43 ± 0.028, P= 0.005) in athletes I
vs athletes II, respectively.
This comes in agreement with Sharma et al.10 who showed
that athletes have a signiﬁcantly longer QTc than nonathletes
(P< 0.05) in a study done to more than 1000 athletes
(391 ± 27 vs 379 ± 29, P< 0.05) in athletes vs control,
respectively, but in disagreement with J-B Langdeau et al.7
who did his study on 100 athletes vs 50 control (415.8 ± 9.4
vs 406.4 ± 2.1, P> 0.05) in athletes vs control, respectively.
Compared to controls, in our study PR interval showed no
signiﬁcant statistical difference (149.03 ± 11.821 vs 139.57 ±
27.67, P= 0.076) in athletes I vs control, respectively PR
interval showed no signiﬁcant statistical difference (143.59 ±
24.87 vs 139.57 ± 27.67, P= 0.55) in athletes II vs control,
respectively. Compared to themselves after one year of profes-
sional training, PR interval showed a non-signiﬁcant increase
(149.03 ± 11.821 vs 143.95 ± 24.844 ms (P= 0.237) in ath-
letes I vs athletes II, respectively.
This comes in disagreement with S Sharma, 2002 who
showed in a study done on 1000 junior athletes in the same
age and sex of our study group that PR interval is more pro-
longed in athletes than nonathletes (153 ± 20 vs 140 ± 18,
P< 0.05) in athletes vs control, respectively.10
Compared to controls, in our study the QRS showed no sig-
niﬁcant statistical difference (101.15 ± 3.661 vs 100.52 ±
5.867, P= 0.465) in athletes I vs control, respectively. QRS
showed no signiﬁcant statistical difference (102.74 ± 6.561 vs
100.25 ± 5.867, P= 0.125) in athletes II vs control, respec-tively. Compared to themselves after one year of professional
training, QRS showed no signiﬁcant statistical difference
(101.15 ± 3.66 vs 102.74 ± 6.561, P= 0.2771) in athletes I
vs athletes II, respectively.
This comes in disagreement with S Sharma, 2002 who
showed in a study done on 1000 junior athletes in the same
age and sex of our study group that the QRS duration was
more prolonged in athletes than nonathletes (92 vs 89 ms,
P< 0.0001), respectively.10
This difference between our study and that of S Sharma
may be due to the smaller number of our study group (50 pa-
tients) in comparison to this study that comprised 1000 junior
athletes.10
Tanji11 said that in young endurance athletes, the electro-
cardiogram may show several abnormalities such as an in-
crease in QRS voltage, that can make it difﬁcult to convince
oneself that there is no hypertensive cardiac involvement. In
some cases, an echocardiogram with a Doppler evaluation of
diastolic function can help in evaluating young athletes with
abnormal electrocardiograms for structural heart disease.
4.3. Regarding Echo parameters
Compared to controls, in our study the septal wall in diastole
(SWd) was not signiﬁcantly different (0.93 ± 0.124 vs
1.07 ± 0.179, P> 0.05) in athletes I vs control, respectively.
SWd was signiﬁcantly thicker (1.21 ± 0.232 vs 1.07 ± 0.179,
P= 0.012) in athletes II vs control, respectively. Compared
to themselves after one year of professionaltraining, SWd Showed
a signiﬁcant increase (0.93 ± 0.124 vs 1.21 ± 0.232, P <
0.001) in athletes I vs athletes II, respectively.
This comes in agreement with Piraye Kervancioglu who
showed that football players were shown to have signiﬁcantly
higher values than the control group for SWd (0.98 ± 0.13 vs
0.85 ± 0.09, P< 0.05) in a study on a total of 40 male football
players.7
Compared to Controls, in our study the posterior wall in
diastole (PWd) was not signiﬁcantly different (0.90 ± 0.106
vs 1.07+0.225, P> 0.05) in athletes I vs control, respectively.
PWd showed no signiﬁcant statistical difference (1 ± 0.20 vs
1.07 ± 0.225, P= 0.202) in athletes II vs control, respectively.
Compared to themselves after one year of professional training,
PWd showed signiﬁcant increase (0.90 ± 0.106 vs 1 ± 0.20,
p0.008) in athletes I vs athletes II, respectively.
This came in disagreement with Piraye Kervancioglu who
showed that there was no signiﬁcant difference between the
PWd of the football players and control group (0.85 ± 0.09
vs 0.81 ± 0.08, P= 0.91).7
Compared to controls, in our study Ejection fraction EF
showed a signiﬁcant increase (60.94 ± 3.084 vs 54.14 ±
13.063, P 0.005) in athletes I vs control, respectively. EF re-
mained signiﬁcantly greater (60.48 ± 10.53 vs 54.14 ± 13.06,
P= 0.04) in athletes II vs control, respectively. Compared to
themselves after one year of professional training, EF was not
signiﬁcantly different (60.94 ± 3.08 vs 60.48 ± 10.53, P=
0.85) in athletes I vs athletes II, respectively.
This comes in agreement with Piraye Kervancioglu who
showed that football players were shown to have signiﬁcantly
higher values than the control group for EF (69.42 ± 4.50 vs
66.28 ± 4.54, P< 0.05).7
Compared to Controls, in our study LVEDd showed no sig-
niﬁcant statistical difference (4.79 ± 0.507 vs 4.69 ± 0.635,
One year cardiac follow up of young world cup football team compared to nonathletes 21P= 0.461) in athletes I vs control, respectively. LVEDd
showed no signiﬁcant statistical difference (4.79 ± 1 vs
4.69 ± 0.635, P= 0.638) in athletes II vs control, respectively.
Compared to themselves after one year of professional training,
LVEDd showed no signiﬁcant statistical difference (4.79 ±
0.507 vs 4.79 ± 1, P= 0.987) in athletes I vs athletes II,
respectively.
This came in disagreement with Piraye Kervancioglu who
showed that there was a signiﬁcantly higher values in LVEDd
in football players than control (5.37 ± 0.38 vs 4.63 ± 0.32,
P> 0.05) which accounts in a large part for the elevated left
ventricular mass LVM in athletes.7
Compared to controls, in our study the left ventricular end
systole diameter LVESd showed no signiﬁcant statistical dif-
ference (3.48 ± 0.19 vs 3.48 ± 0.19, P= 0.483) in athletes I
vs control, respectively. LVESd showed no signiﬁcant statisti-
cal difference (3.19 ± 0.679 vs 3.48 ± 0.19, P= 0.142) in ath-
letes II vs control, respectively. Compared to themselves after
one year of professional training, LVESd showed a signiﬁcant
decrease (3.48 ± 0.19 vs 3.19 ± 0.679, P= 0.016) in athletes
I vs athletes II, respectively.
This comes in disagreement with Eric Abergel who showed
in a study done on 286 cyclists and 52 matched sedentary vol-
unteers (39.7 ± 4.1 vs 31.4 ± 4.1 P< 0.05) in athletes vs con-
trol, respectively.4
Compared to controls, in our study the LA show a signiﬁ-
cant increase (3.28 ± 0.392 vs 2.58 ± 1.321, P= 0.005) in
athletes I vs control, respectively. LA showed a signiﬁcant in-
crease (3.62 ± 0.423 vs 2.58 ± 1.321, P= 0.001) in athletes II
vs control, respectively. Compared to themselves after one year
of professional training, LA showed a signiﬁcant increase
(3.28 ± 0.392 vs 3.62 ± 0.423 P= 0.001) in athletes I vs ath-
letes II, respectively.
This comes in agreement with S Sharma 2002 who showed a
signiﬁcant LA enlargement in athletes vs control in a study on
1000 athletes vs 300 control where 14% of athletes had LA
enlargement vs 1.2% in control P< 0.05.10
Compared to controls, in our study the right ventricle RV
showed no signiﬁcant statistical difference (2.09 ± 0.237 vs
2.27 ± 0.492, P= 0.073) in athletes I vs control, respectively.
RV showed no signiﬁcant statistical difference (2.37 ± 0.565
vs 2.27 ± 0.492, P= 0.431) in athletes II vs control, respec-
tively. Compared to themselves after one year of professional
training, RV was signiﬁcantly increased (2.09 ± 0.237 vs
2.37 ± 0.565, P= 0.01) in athletes I vs athletes II, respectively.
This comes in agreement with Gu¨nther Schneider who
showed that endurance athletes have increased RV dimensions
in a study done on 21 male endurance athletes and 21 pair-
matched untrained control subjects (P< 0.05).12
On the other hand, this comes in disagreement with a study
done by M.K. Erol and Sule Karakelleoglu,13 the study popu-
lation consisted of 36 elite highly-trained male athletes and 16
age-matched healthy sedentary controls. All right ventricular
systolic and diastolic echocardiographic parameters were sim-
ilar in athletes with and without left ventricular hypertrophy
(P> 0.05). The results of this study indicate that right ventric-
ular systolic and diastolic functions do not deteriorate in the
athlete’s heart despite signiﬁcant chamber dilatation. They
suggest that these changes are a normal physiologic adaptation
to prolonged training.
Turpeinen14 also showed that exercise training causes a
number of well known physiological changes in the heart: anincrease in LVEDD and left ventricular wall thicknesses
(IVS and LVPW), stroke volume is increased and heart rate
is decreased during resting conditions.5. Conclusions
Professional football playing in young males results in signiﬁ-
cant cardiovascular changes compared to their control of sed-
entary nonathletic medical students of similar age.
Compared to controls, clinical parameters in athletes
showed a signiﬁcant decrease in systolic blood pressure SBP
and heart rate HR, ECG parameters showed signiﬁcant pro-
longation in RR interval and QTc interval, and Echocardio-
graphic parameters showed a signiﬁcant increase in Left
atrium diameter LA, Septal wall in diastole SWD, and ejection
fraction EF.
Compared to themselves after one year of professional
football playing by young males, ECG parameters showed a
continuing signiﬁcant prolongation in QTc, RR interval, and
Echocardiographic parameters Septal wall in diastole SWD,
Left atrium diameter LA, Right ventricle dimension RV, Pos-
terior wall in diastole PWD and decrease in Left ventricular
end systolic diameter LVESD compared to themselves one
year earlier.
The international concern of Sudden cardiac death among
professional young athletes may be attributed to Structural
heart changes and ECG abnormalities acquired with profes-
sional training.References
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